UTHR

#531
United Therapeutics Corporation - Common Stock
557.7 5 USD
-0.77%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
556.00
563.04
1年のレンジ
272.17
609.35
1日の変化
-0.77%
月次変化
-2.91%
6か月変化
+15.08%
1年の変化
+74.20%
以前の終値
562.0 9
Open
562.7 4
安値
556.0 0
High
563.0 4
ボリューム
159
チャート全体を表示 Full chart

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 23.67 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
17.49
売上高対価格比率
7.33

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

ニュース